欧洲急诊医学大会公布鼻内舒芬太尼-氯胺酮治疗儿童急性疼痛的II/III期研究结果
Intranasal sufentanil-ketamine appears safe, effective for pediatric acute pain
英国谢菲尔德儿童医院团队在欧洲急诊医学大会报告的II/III期研究显示,鼻内固定剂量舒芬太尼-氯胺酮用于急诊儿童中重度急性疼痛,30分钟内88%的患者疼痛强度评分不超过4分。
Intranasal sufentanil-ketamine is fast-acting and appears to be well tolerated and effective at curbing acute pain for pediatric patients in the emergency department, according to a study presented at the annual European Emergency Medicine Congress, held Sept. 23–27 in Paris.
Shammi Ramlakhan, M.B.B.S., from Sheffield Children's Hospital in the United Kingdom, and colleagues evaluated the efficacy, safety and tolerability of a fixed-dose intranasal formulation of sufentanil-ketamine. The phase 2/3 study included 152 patients (aged ≥1 to <18 years) presenting to the emergency department with moderate-to-severe acute pain.
The researchers found that 54% and 88% of participants had a pain intensity score of ≤4 at 15 and 30 minutes, respectively. Nearly all patients (95.4%) achieved a 30% reduction in pain intensity, and 86.2% achieved a 50% reduction from baseline at 30 minutes. Across all age groups, the median treatment satisfaction score was 5 out of 5 (very satisfied), with 92% acceptability.
Just under half of participants (49.7%) reported at least one adverse event, and 46.5% reported treatment-emergent adverse events. No severe adverse events were reported, and nearly all (94%) were mild. Across all age groups, sedation scores were a median of 0 (awake and alert) or 1 (minimally sedated).
"Pain in children remains underrecognized and undertreated. Our research shows that this drug can provide rapid and meaningful pain relief for children being treated in the emergency department," Ramlakhan said in a statement. "This also gives doctors a simple and effective option for treating their patients where very few options currently exist."
Key medical concepts
Who's behind this story?
Sadie Harley
BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →
Alexander Pol
PhD nano-engineering from Delft University. Published researcher and journal reviewer. Brings scientific insight to content standards. Full profile →
Copyright © 2026 HealthDay. All rights reserved.
Citation: Intranasal sufentanil-ketamine appears safe, effective for pediatric acute pain (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-intranasal-sufentanil-ketamine-safe-effective.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
来源:Medical Xpress · medicalxpress.com